Acea Therapeutics Inc.

San Diego, CA Part of Vivasor, Inc.

UEI: LVKXKHFJ3FK9
CAGE: 87B20
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Active through Jul 8, 2027

Company facts

Self-certified in SAM.gov: For Profit Organization
Entity structure: Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov: 325412 Pharmaceutical Preparation Manufacturing

541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Corporate family: Sorrento Therapeutics Inc. Parent Vivasor, Inc. GED6FTJMNTA5

Acea Therapeutics Inc.
SAM.gov registration date: Nov 9, 2018
Physical address: 9380 Judicial Dr, San Diego, CA 92121, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Jul 23, 2026.

Contract awards

Award	Agency	Obligated	Awarded
Real-time estrogen-dependent cell growth analysis. 68HE0B20P0376	Office of Research and Development (EPA)	$10,740	Aug 26, 2020

Quick answers

Is Acea Therapeutics Inc. registered in SAM.gov?

Yes. Acea Therapeutics Inc.'s SAM.gov registration is active through July 8, 2027.

What is Acea Therapeutics Inc.'s most recent federal award?

Acea Therapeutics Inc.'s most recent federal contract award is Real-time estrogen-dependent cell growth analysis (68HE0B20P0376), from Office of Research and Development (EPA), on August 26, 2020.

On GovTribe

See Acea Therapeutics Inc.'s full federal record

Federal contract awards
Funding analysis by agency, NAICS and set-aside
Similar vendors

Try for free Login